Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion type Assertion NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_head.
- NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion description "[In the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 A 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 A 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 A 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 A 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 A 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_provenance.
- NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion evidence source_evidence_curated NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_provenance.
- NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion SIO_000772 23666239 NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_provenance.
- NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion wasDerivedFrom ctd_human-20150221 NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_provenance.
- NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_assertion wasGeneratedBy ECO_0000218 NP21385.RACclz93o3OZsZp-nm8nY_cupx8Q8w6Y4DkWq311JLCnk130_provenance.